Parallel Advisors’s Wave Life Sciences WVE Stock Holding History

Parallel Advisors’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32K	Buy	228 +133	+140%	+$882	﹤0.01%	3624
2026 Q1	$689	Hold	95	–	–	﹤0.01%	3608
2025 Q4	$1.61K	Hold	95	–	–	﹤0.01%	3194
2025 Q3	$695	Hold	95	–	–	﹤0.01%	3288
2025 Q2	$618	Hold	95	–	–	﹤0.01%	3282
2025 Q1	$768	Hold	95	–	–	﹤0.01%	3170
2024 Q4	$1.18K	Hold	95	–	–	﹤0.01%	3081
2024 Q3	$779	Hold	95	–	–	﹤0.01%	3089
2024 Q2	$474	Hold	95	–	–	﹤0.01%	3104
2024 Q1	$586	Hold	95	–	–	﹤0.01%	3029
2023 Q4	$480	Hold	95	–	–	﹤0.01%	3066
2023 Q3	$546	Hold	95	–	–	﹤0.01%	3088
2023 Q2	$346	Hold	95	–	–	﹤0.01%	3171
2023 Q1	$411	Buy	+95	New	+$435	﹤0.01%	3164
2021 Q3	–	Sell	-121	Closed	-$1K	–	3291
2021 Q2	$1K	Buy	+121	New	+$791	﹤0.01%	2854
2020 Q1	–	Sell	-600	Closed	-$5K	–	2678
2019 Q4	$5K	Buy	+600	New	+$14.7K	﹤0.01%	1981

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Parallel Advisors's WVE Position: Q2 2026 in Review

Parallel Advisors increased its Wave Life Sciences (WVE) stake by 140% in Q2 2026, buying an estimated $882 and bringing the position to 228 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Parallel Advisors first reported a position in WVE in Q4 2019 and has held it in 16 quarters since. The position peaked at $5K in Q4 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Parallel Advisors held 228 shares of Wave Life Sciences worth $1.32K as of Q2 2026.
Parallel Advisors bought 133 Wave Life Sciences shares in Q2 2026, an estimated $882.
Wave Life Sciences made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3624 holding.
Parallel Advisors first reported a position in Wave Life Sciences in Q4 2019 and has held it in 16 quarters since.
Parallel Advisors's Wave Life Sciences position peaked at $5K in Q4 2019.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.